Your browser is no longer supported. Please, upgrade your browser.
SVRA Savara Inc. daily Stock Chart
SVRA [NASD]
Savara Inc.
Index- P/E- EPS (ttm)-1.86 Insider Own15.73% Shs Outstand57.36M Perf Week3.83%
Market Cap122.10M Forward P/E- EPS next Y-1.12 Insider Trans0.00% Shs Float44.19M Perf Month-4.69%
Income-81.50M PEG- EPS next Q-0.24 Inst Own46.30% Short Float5.89% Perf Quarter6.55%
Sales- P/S- EPS this Y-5.70% Inst Trans16.63% Short Ratio8.15 Perf Half Y141.58%
Book/sh1.52 P/B1.61 EPS next Y8.00% ROA-59.90% Target Price- Perf Year-77.82%
Cash/sh2.10 P/C1.16 EPS next 5Y- ROE-79.80% 52W Range0.69 - 11.39 Perf YTD-45.54%
Dividend- P/FCF- EPS past 5Y34.70% ROI- 52W High-78.58% Beta0.93
Dividend %- Quick Ratio13.90 Sales past 5Y- Gross Margin- 52W Low253.62% ATR0.20
Employees42 Current Ratio13.90 Sales Q/Q- Oper. Margin- RSI (14)52.84 Volatility7.95% 8.87%
OptionableYes Debt/Eq0.28 EPS Q/Q20.10% Profit Margin- Rel Volume1.44 Prev Close2.45
ShortableYes LT Debt/Eq0.28 EarningsMay 07 AMC Payout- Avg Volume319.28K Price2.44
Recom2.20 SMA201.24% SMA506.28% SMA20015.14% Volume458,532 Change-0.41%
Jun-13-19Reiterated H.C. Wainwright Buy $22 → $6
Jun-13-19Downgrade Ladenburg Thalmann Buy → Neutral $21 → $3
Jun-13-19Downgrade JMP Securities Mkt Outperform → Mkt Perform
Aug-13-18Resumed ROTH Capital Neutral $12
Jan-03-18Initiated Ladenburg Thalmann Buy $35
Sep-27-17Resumed ROTH Capital Buy $40
Sep-22-17Initiated Jefferies Buy $20
Sep-11-17Initiated JMP Securities Mkt Outperform $20
May-27-20 04:05PM  Savara to Present at the Jefferies Virtual Healthcare Conference Business Wire
May-08-20 08:05AM  Savara Announces Change of Date for 2020 Annual Meeting of Stockholders Business Wire -7.84%
May-07-20 04:05PM  Savara Reports First Quarter 2020 Financial Results and Provides Business Update Business Wire +5.81%
Apr-30-20 04:05PM  Savara to Report First Quarter 2020 Financial Results and Provide Business Update Business Wire -5.86%
Apr-15-20 11:26AM  Are Insiders Buying Savara Inc. (NASDAQ:SVRA) Stock? Simply Wall St.
Apr-02-20 04:05PM  Savara Obtains Global Rights to Develop and Commercialize Apulmiq Business Wire -7.00%
Mar-30-20 04:05PM  Savara Provides Business Update in Response to COVID-19 Pandemic Business Wire +9.30%
Mar-23-20 07:53AM  Savara Sees Hammer Chart Pattern: Time to Buy? Zacks
Mar-12-20 04:05PM  Savara Reports Fourth Quarter / Year-End 2019 Financial Results and Provides Business Update Business Wire +8.05%
02:30PM  Savara, Inc. to Host Earnings Call ACCESSWIRE
Mar-11-20 09:23AM  Is a Surprise Coming for Savara (SVRA) This Earnings Season? Zacks -7.45%
Mar-05-20 08:05AM  Savara to Report Fourth Quarter/Year-End 2019 Financial Results and Provide Business Update Business Wire
Jan-16-20 11:21AM  Is Savara Inc. (NASDAQ:SVRA) A Volatile Stock? Simply Wall St.
Jan-06-20 09:14AM  In the money Jan. 6: Drug, burger makers report multimillion-dollar fundings American City Business Journals -14.74%
Jan-02-20 09:30AM  Are Options Traders Betting on a Big Move in Savara (SVRA) Stock? Zacks -8.93%
Dec-30-19 08:05AM  Savara Granted Breakthrough Therapy Designation for Molgradex for the Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Business Wire +183.82%
Dec-20-19 11:51AM  Savara Announces Private Placement of $26.8 Million, With Total Potential Proceeds of $75.0 Million Business Wire +7.43%
Dec-19-19 04:18PM  Is Savara, Inc. (SVRA) A Good Stock To Buy? Insider Monkey
Dec-03-19 04:05PM  Savara Announces the Appointment of Dr. An van Es-Johansson to Board of Directors Business Wire
11:17AM  2 Falling Knives for Investors to Consider GuruFocus.com
Nov-27-19 04:05PM  Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Business Wire
Nov-26-19 04:05PM  Savaras COO and CMO to Present at the Evercore ISI 2nd Annual HealthCONx Conference Business Wire
Nov-18-19 08:05AM  Savara Appoints Badrul Chowdhury, M.D., Ph.D as Chief Medical Officer Business Wire +21.07%
Nov-15-19 02:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. - SVRA ACCESSWIRE
Nov-13-19 02:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc.  SVRA GlobeNewswire
Nov-12-19 04:05PM  Savara to Present at the Stifel 2019 Healthcare Conference Business Wire -6.71%
Nov-11-19 06:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. - SVRA ACCESSWIRE
Nov-07-19 05:50PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. - SVRA GlobeNewswire
04:05PM  Savara Reports Third Quarter 2019 Financial Results and Provides Business Update Business Wire
Oct-31-19 04:05PM  Savara to Report Third Quarter 2019 Financial Results and Provide Business Update Business Wire
Oct-17-19 02:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. - SVRA ACCESSWIRE
Oct-15-19 12:42PM  Have Insiders Been Buying Savara Inc. (NASDAQ:SVRA) Shares? Simply Wall St. +6.08%
Oct-11-19 07:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. - SVRA ACCESSWIRE
Oct-07-19 07:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. - SVRA ACCESSWIRE
Oct-03-19 11:00AM  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Savara Inc. (SVRA) ACCESSWIRE
10:18AM  Company News For Oct 3, 2019 Zacks
Oct-02-19 06:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc.  SVRA GlobeNewswire -58.47%
08:02AM  Savara Announces FDA Response From Type C Meeting on Molgradex for aPAP Development Program Business Wire
Sep-18-19 04:15PM  Savara to Present Comprehensive Data From Pivotal Phase 3 IMPALA Study at 2019 ERS Business Wire
Sep-02-19 11:39AM  Mangrove Partners Return, AUM, and Holdings Insider Monkey
Aug-08-19 04:02PM  Savara Reports Second Quarter 2019 Financial Results and Provides Business Update Business Wire
Jul-31-19 08:02AM  Savara to Present at the 39th Annual Canaccord Genuity Global Growth Conference Business Wire
Jul-15-19 03:49PM  Some Savara (NASDAQ:SVRA) Shareholders Have Taken A Painful 79% Share Price Drop Simply Wall St.
Jun-25-19 08:52PM  Hedge Funds Have Never Been More Bullish On Savara, Inc. (SVRA) Insider Monkey -5.06%
Jun-20-19 09:45AM  The Zacks Analyst Blog Highlights: Amgen, Alexion, Regeneron, Allergan and Savara Zacks
Jun-19-19 10:29AM  Biotech Stock Roundup: Amgen Gets FDA Nod for Kanjinti, Regeneron Presents Data Zacks +13.87%
Jun-13-19 04:02PM  Savara to Present at the JMP Securities Life Sciences Conference Business Wire -75.21%
12:55PM  Savara Plunges After Lung Disease Drug Fails Phase 3 Trial TheStreet.com
12:33PM  Here's Why Savara Pharmaceuticals Collapsed Today Motley Fool
09:50AM  Savara Plunges on Failure of Late-Stage Study on Molgradex Zacks
Jun-12-19 05:48PM  Savara Shares Slammed on Failed Phase 3 Drug Study TheStreet.com
04:41PM  Savara stock plummets 75% after drug study fails to hit target MarketWatch
04:02PM  Savara Announces Results of IMPALA, a Phase 3 Study of Molgradex for the Treatment of Autoimmune Alveolar Pulmonary Proteinosis (aPAP) Business Wire
Jun-10-19 09:03AM  Implied Volatility Surging for Savara (SVRA) Stock Options Zacks +8.88%
May-17-19 12:20PM  Savara Inc. (SVRA) Q1 2019 Earnings Call Transcript Motley Fool
May-16-19 11:17AM  Savara Inc. (NASDAQ:SVRA) Is Expected To Breakeven Simply Wall St.
May-15-19 09:00AM  Savara Inc (SVRA) Upgraded to Buy: Here's Why Zacks
May-09-19 04:02PM  Savara Reports First Quarter 2019 Financial Results and Provides Business Update Business Wire
May-06-19 08:02AM  Savara Announces Molgradex Received Fast Track Designation by FDA for Treatment of Autoimmune Pulmonary Alveolar Proteinosis Business Wire
May-02-19 08:02AM  Savara to Report First Quarter 2019 Financial Results and Provide Business Update Business Wire
Apr-09-19 09:00AM  Savara Inc (SVRA) Upgraded to Buy: Here's Why Zacks
Apr-02-19 08:00AM  Savara to Present at the H.C. Wainwright Global Life Sciences Conference in London ACCESSWIRE +6.46%
Apr-01-19 08:00AM  Savara Initiates Phase 2a Clinical Study of Molgradex for the Treatment of NTM Lung Infection in People Living with Cystic Fibrosis ACCESSWIRE +7.19%
Mar-13-19 08:52PM  Savara Inc. (SVRA) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:02PM  Savara Reports Fourth Quarter And Full Year 2018 Financial Results And Provides Business Update ACCESSWIRE
Mar-12-19 03:18PM  Did Savara Inc. (NASDAQ:SVRA) Insiders Buy Up More Shares? Simply Wall St. +5.47%
Mar-06-19 08:00AM  Savara To Report Q4/Year-End 2018 Financial Results And Business Update On March 13, 2019 ACCESSWIRE -9.09%
Mar-04-19 08:00AM  Savara to Present at the 39th Annual Cowen and Company Healthcare Conference ACCESSWIRE
Feb-06-19 08:00AM  Savara Provides Update on IMPALA and AVAIL Pivotal Clinical Studies GlobeNewswire
Jan-16-19 09:29AM  Could The Savara Inc. (NASDAQ:SVRA) Ownership Structure Tell Us Something Useful? Simply Wall St.
Dec-21-18 11:18PM  Savara, Inc. (SVRA)Hedge Funds Are Snapping Up Insider Monkey
Dec-19-18 08:00AM  Savara Announces Interim Results for OPTIMA Clinical Study of Molgradex for the Treatment of NTM GlobeNewswire -9.14%
Nov-16-18 08:00AM  Savara to Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27th GlobeNewswire
Nov-07-18 04:02PM  Savara Reports Third Quarter 2018 Financial Results and Provides Business Update GlobeNewswire
Nov-01-18 08:00AM  Savara to Host Third Quarter 2018 Financial Results and Business Update Conference Call on November 7, 2018 GlobeNewswire
Oct-31-18 08:00AM  Savara Completes Enrollment in Molgradex OPTIMA Clinical Study for the Treatment of NTM GlobeNewswire
Oct-15-18 02:09PM  A Look At The Intrinsic Value Of Savara Inc (NASDAQ:SVRA) Simply Wall St.
08:00AM  Savara Completes Enrollment in Pivotal Molgradex Impala Clinical Study for the Treatment of aPAP GlobeNewswire
Sep-27-18 08:00AM  Savara Provides Enrollment Update on Molgradex Impala and OPTIMA Clinical Studies and Reaffirms Guidance for Topline Data GlobeNewswire
Aug-09-18 04:03PM  Savara Reports Second Quarter 2018 Financial Results and Provides Positive Business Update GlobeNewswire
03:30PM  Savara, Inc. to Host Earnings Call ACCESSWIRE
Aug-02-18 08:00AM  Savara to Host Second Quarter 2018 Financial Results and Business Update Conference Call on Thursday, August 9, 2018 GlobeNewswire
Jul-26-18 03:49PM  Philadelphia Angel Group Keiretsu Joins Orphan Lung Disease Company, Savara, as It Rings Nasdaq Opening Bell Newsfile -10.57%
09:15AM  Savara Announces Pricing of Public Offering of Common Stock GlobeNewswire
Jul-25-18 04:16PM  Savara Announces Proposed Public Offering of Common Stock GlobeNewswire
04:01PM  Savara Provides Positive Update on Development and Commercial Preparations of Molgradex, Including Expansion into NTM In CF GlobeNewswire
Jul-23-18 08:00AM  Savara to Ring Nasdaq Stock Market Opening Bell on July 23rd GlobeNewswire
Jun-25-18 08:00AM  Savara Joins Russell 3000® Index GlobeNewswire
Jun-13-18 08:00AM  Savara to Present at JMP Securities 2018 Life Sciences Conference on June 20th GlobeNewswire
Jun-12-18 03:40PM  Dive into the latest metric to compare Austin public companies: CEO pay ratios American City Business Journals
Jun-08-18 12:11PM  Why Savara Inc. Is Soaring Today Motley Fool +21.13%
May-29-18 08:00AM  Savara Provides Update on Case Reports of Inhaled Granulocyte-Macrophage Colony Stimulating Factor for the Treatment of Nontuberculous Mycobacteria Infection GlobeNewswire +17.57%
May-23-18 08:25AM  New Research: Key Drivers of Growth for PCM, WGL, Savara, ConforMIS, Sandy Spring, and West Pharmaceutical Services Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
May-15-18 12:26PM  UPDATE -- Savara to Present at Bank of America Merrill Lynch 2018 Healthcare Conference on May 15th GlobeNewswire
May-11-18 08:00AM  Savara to Present at Bank of America Merrill Lynch 2018 Healthcare Conference on May 17th GlobeNewswire
May-09-18 04:02PM  Savara Reports First Quarter 2018 Financial Results and Provides Business Update GlobeNewswire
May-01-18 08:00AM  Savara to Host First Quarter 2018 Financial Results and Business Update Conference Call on Wednesday, May 9, 2018 Marketwired
Mar-30-18 07:45AM  Report: Exploring Fundamental Drivers Behind Mast Therapeutics, Pebblebrook Hotel Trust, Smart, Waddell & Reed Financial, Quality Care Properties, and Meridian Waste Solutions New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Mar-15-18 08:00AM  Savara to Present at 28th Annual Oppenheimer & Co. Healthcare Conference on March 20th Marketwired
Mar-14-18 04:47PM  Mast reports 4Q loss Associated Press
Savara Inc. operates as an orphan lung disease company. Its lead product candidate includes Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis; and in Phase IIa development stage for treating nontuberculous mycobacterial lung infection. The company is also developing AeroVanc, an inhaled vancomycin that is in Phase III stage for the treatment of methicillin-resistant Staphylococcus aureus lung infection in individuals living with cystic fibrosis. Savara Inc. is headquartered in Austin, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McCracken Joseph SDirectorJul 05Option Exercise1.1339,50644,63799,372Jul 08 04:05 PM
RAMSAY DAVID ADirectorJun 28Buy2.3435,15782,309122,142Jun 28 05:36 PM
RAMSAY DAVID ADirectorJun 27Buy2.4122,30053,77486,985Jun 28 05:36 PM
RAMSAY DAVID ADirectorJun 26Buy2.389002,14264,685Jun 28 05:36 PM
RAMSAY DAVID ADirectorJun 18Buy2.3515,21535,80563,785Jun 19 05:58 PM
RAMSAY DAVID ADirectorJun 17Buy2.3825,00059,55048,570Jun 19 05:58 PM